Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Betticher

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The Annals of Thoracic Surgery|June 25, 2005
Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancerDidier Lardinois, Hans Suter, Hassan Hakki, et al.
Clinical Colorectal Cancer|April 28, 2016
Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)Klazien Matter-Walstra, Matthias Schwenkglenks, Daniel Betticher, et al.
Proteomics|May 24, 2006
Clinical proteomics: study of a cryogelDaniel Robert, Stefano Barelli, David Crettaz, et al.
Leukemia & Lymphoma|August 22, 2015
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U Mueller, Sandra Keller, Katja Seipel, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 1, 2022
Impact of concomitant popliteal vein thrombosis in patients with acute iliofemoral deep vein thrombosis treated with endovascular early thrombus removalVincent Frey, Tim Sebastian, Stefano Barco, et al.
Hematological Oncology|September 5, 2019
Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter?Sebastian Moser, Ulrike Bacher, Barbara Jeker, et al.
Hematological Oncology|January 25, 2018
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftUrsina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, et al.
European Journal of Cancer Care|September 21, 2022
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional surveyChantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2015
Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial)Anca Franzini, Florent Baty, Ina I Macovei, et al.
Clinical Genitourinary Cancer|September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment RegistryFrank Stenner, Sacha I Rothschild, Daniel Betticher, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Annals of Thoracic Surgery|June 25, 2005
Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancerDidier Lardinois, Hans Suter, Hassan Hakki, et al.
Clinical Colorectal Cancer|April 28, 2016
Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)Klazien Matter-Walstra, Matthias Schwenkglenks, Daniel Betticher, et al.
Proteomics|May 24, 2006
Clinical proteomics: study of a cryogelDaniel Robert, Stefano Barelli, David Crettaz, et al.
Leukemia & Lymphoma|August 22, 2015
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U Mueller, Sandra Keller, Katja Seipel, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 1, 2022
Impact of concomitant popliteal vein thrombosis in patients with acute iliofemoral deep vein thrombosis treated with endovascular early thrombus removalVincent Frey, Tim Sebastian, Stefano Barco, et al.
Hematological Oncology|September 5, 2019
Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter?Sebastian Moser, Ulrike Bacher, Barbara Jeker, et al.
Hematological Oncology|January 25, 2018
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftUrsina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, et al.
European Journal of Cancer Care|September 21, 2022
Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional surveyChantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2015
Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial)Anca Franzini, Florent Baty, Ina I Macovei, et al.
Clinical Genitourinary Cancer|September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment RegistryFrank Stenner, Sacha I Rothschild, Daniel Betticher, et al.
Pageof 4